跳至主要内容
临床试验/NCT02799914
NCT02799914撤回不适用

Evaluation of the Sinus-Venous Stent for the Treatment of Iliofemoral Venous Occlusive Disease: A Monocenter Post Market Clinical Follow-up Study

be Medical1 个研究点 分布在 1 个国家开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Stent patency

研究概览

简要总结

Post market clinical follow-up study about the Sinus-venous stent. Patients with venous iliofemoral occlusive disease are treated with the Sinus-venous stent. This observational study will provide 1 year data about safety and efficacy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age at study entry is at least 18 years.
  • Patient must sign the informed consent form prior to the index-procedure.
  • Patient suffers from acute or chronic venous occlusive disease indicated to be treated with a venous stent.
  • Target lesion is located in the femoral vein, common femoral vein, external iliac vein, or common iliac vein.

排除标准

  • Intolerance to anticoagulant medication.
  • Contra-indication for prolonged anticoagulant treatment.
  • Life expectancy less than 1 year.
  • Target vessel has been stented before.
  • Coagulopathy or known uncorrectable bleeding diathesis.
  • Recent (<1 year) pulmonary embolism.
  • Known hypersensitivity to nitinol and/or nickel.
  • Known to be, or suspected of being unable to comply with the study protocol (e.g. no permanent address, known to be non-compliant or presenting an unstable psychiatric history).
  • Legal incapacity and/or other circumstances rendering the patient unable to understand the nature, scope and possible impact of the study.
  • Patients in custody by juridical order.
  • Patients who do not agree to the transmission of their coded data within the liability of documentation and notification.
  • Close affiliation with the investigational site: e.g. a close relative of the investigator or a possibly dependent person (e.g. employee or student of the investigational site).

结局指标

主要结局

Stent patency

时间窗: 12 months

Patency broken down in primary patency, assisted primary patency and secondary patency

次要结局

  • Technical success(Index-procedure (intraoperative))
  • Revised venous clinical severity score(12 months)
  • Mortality(12 months)
  • Procedural complications(Index-procedure)
  • Reintervention(12 months)

研究者

发起方
be Medical
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验